Vimarsana
Biggest News Aggregation in the World

Page 3 - Georg Schett News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Georg Schett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Georg Schett Today - Breaking & Trending Today

CAR-T for lupus: the 'tip of the iceberg' for cell therapy in autoimmune disease - Vimarsana News

CAR-T for lupus: the 'tip of the iceberg' for cell therapy in autoimmune disease

BioPharma

CAR T-Cell Approach to Autoimmune Disease Gains Traction - Vimarsana News

CAR T-Cell Approach to Autoimmune Disease Gains Traction

Worries about vaccine responsiveness relieved; Big Pharma gets interested

Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

– Initial clinical data from CABA-201 treated patients in Phase 1/2 trials for lupus and/or myositis expected in the first half of 2024, with the ...

CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus - Vimarsana News

CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus

New research at ACR Convergence 2023, the American College of Rheumatology's annual meeting, demonstrates that CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus while maintaining a robust response to vaccines.

Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2023 Earnings Call Transcript - Vimarsana News

Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2023 Financial Results Conference Call and Business Update.